Drug Interactions Flashcards

1
Q

phase 1 reactions

A

oxidation, reduction, hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

phase 2 reactions

A

generally terminates the activity of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Enzyme metabolism for elimination through the kidneys - the kidneys the drug to be more….

A

hydrophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

warfarin is metabolized by…and converts them into…

A

CYP 2C9, inactive metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

inducers

A

increase the level/activity of the metabolizing enzyme that decreases the amount of active drug in the system– lowers the blood levels of the substrate…most of the time - except for with prodrugs (bioactivation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rifampin

A

one of the strongest induces of many enzymes - (1A2, 2C8, 2C9, 2C19, 3A4 and P-glycoprotein pump)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

A patient is taking warfarin and is prescribed Rifampin…what needs to happen

A

the dose of warfarin needs to be increased by 100-300% due to 2C9 induction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

inhibitors

A

inhibit the activity of the enzymes - less drug metabolism ….. potential drug toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

inhibitors

A

inhibit the activity of the enzymes - less drug metabolism ….. potential drug toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

patient is prescribed warfarin and amiodarone….what is the result

A

amiodarone is a 2C9 inhibitor…inhibiting metabolism of warfarin and increasing serum levels - decrease warfarin dose by 30-50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Common drug classes that use the 2D6 system

A

pain and psychiatric drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

explain codeine’s metabolism

A

converted to it’s active form (morphine) using 2D6 enzymes. patients who have less 2D6 activity will be sub-therapeutic, can also have ultra rapid metabolizers that can cause extreme overdose for the patient and potentially fatal results

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

explain the drug interaction between paroxetine and codiene

A

paroxetine inhibits 2D6 –> a need for a higher codeine dose to have desired effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

inhibition lag time

A

inhibition is fast (at most takes days for effect) and ends quickly upon inhibitor discontinuation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

induction lag time

A

induction requires additional enzyme production, this takes time…full effect may not be present for up to 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

discontinuation of an inducer..what do you do

A

it will take 2-4 weeks for the induction to disappear completely - enzymes must die off based on their half life.

17
Q

strong inducers

A

> 80% decrease in AUC

18
Q

strong inhibitors

A

> 5 fold increase in AUC

19
Q

moderate inducers

A

50-80% decrease in AUC

20
Q

moderate inhibitors

A

> 2 but

21
Q

weak inducers

A

20-50% decrease in AUC

22
Q

weak inhibitors

A

> 1 fold but

23
Q

P-glycoproteins (P-gp) - explain their function

A

efflux proteins that pump drug back into the gut to exit the body

24
Q

P-gp inducers cause

A

creastion of more p-gp pumps and drug levels decrease

25
Q

P-gp inhibitors cause

A

inhibition of pgp pumps and increased drug levels

26
Q

Strong P-gp inducers

A

rifampin, avasimibe, carbamazepine, phenytoin, st. john’s wort, tipranavir/ritonavir

27
Q

strong p-gp inhibitors

A

itraconazole/ketoconazole, verapamil, ritonavir, lopinavir/ritonavir, indinavir/ritonavir, conivaptan, clarithromycin, erithromycin, amiodarone, quinidine

28
Q

p-gp substrates

A

aliskiren, colchicine, dabigatran, cyclosporin, digoxin, fexofenadine, posaconazole, fanolazine, rivaroxaban, saxagliptin, tarcolimus

29
Q

amiodarone drug interactions

A

digoxin, warfarin, quinidine, procainamide (decrease dose by 30-50%), use lower doses of simvastatin, lovastatin, and adorvastatin.

30
Q

digoxin drug interactions

A

level increases with decreased renal function or hypokalemia, amiodarone (drug level will increase). concern with drugs that lower heart rate - diltiazem and verapamil, beta blockers, amiodarone, dexmedetomidine, clonidine, and opioids

31
Q

organophosphate poisoning

A

bradycardia is one s symptom (occurs most commonly with farm workers d/t pesticide exposure)

32
Q

drugs you should avoid grapefruit juice with

A

simvastatin, lovastatin, atorvastatin, CCB’s (this will cause increased drug concentration), rivaroxaban/ticagrelor (increased bleeding risk), qt prolongers - lurasidone, quinidine, citalopram etc (risk of torsades). not a gut interaction problem this is a drug metabolizing enzyme inactivation problem

33
Q

lamotrigine drug interactions

A

valproate (increases risk for severe skin rash) any lam inhibitor will require a lower dose titration, inducers will require a higher dose (impair seizure control)

34
Q

MAOI drug interactions

A

can cause serotonin syndrome and hypertensive crisis - monoamines will reduce metabolism with maoi’s - dopamine, epinephrine, norepi, serotonin and tyramine. DO NOT USE MAOIS with epi and analogies (pseudophedrine etc), bupropion, buspirone, linezolid, lithium, meperidine, SSRIs, SNRIs, tcas, TRAMADOL, LEVADOPA, MIRAZAPINE, DEXTROMETHORPHAN, CYCLOBENZAPRINE, TRIPTANS, ST JOHNS WORT, PROCARBAZINE, LORCASERIN

35
Q

what happens within you take tramadol or hydrocodone with a 2d6 inhibitor

A

tramadol - decreased active drug in the body bc prodrug activation is inhibited
hydcodone - will have increased drug in the system - more chance of resp depression etc

36
Q

hydrocodone, fentanyl, oxycodone and methadone are primarily metabolized by:

A

3A4 - AVOID 3A4 INHIBITORS WITH THESE DRUGS AND WATCH FOR SUBTHERAPEUTIC RESPONSES WITH INDUCERS

37
Q

PDE5-INHIBITORS DRUG INTERACTIONS

A

ADDITIVE HYPOTENSION/DIZZINESS HEADACHE ETC WITH ALPHA BLOCKERS FOR PROSTATE ENLARGEMENT